AWM
HRMY icon

Avior Wealth Management’s Harmony Biosciences HRMY Stock Holding History

Avior Wealth Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6
Closed -$201 – 2920
2024
Q1 		$201 Buy
+6
New +$193 ﹤0.01% 2873

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Avior Wealth Management's HRMY Position: Q2 2024 in Review

Avior Wealth Management sold out of Harmony Biosciences (HRMY) in Q2 2024, closing a stake of 6 shares — an estimated $201 sold.

Avior Wealth Management first reported a position in HRMY in Q1 2024 and held it in 1 quarter. The position peaked at $201 in Q1 2024. 219 funds tracked by Wall St. Rank hold HRMY as of Q2 2024.

  • Avior Wealth Management reported no remaining Harmony Biosciences position as of Q2 2024 after selling out during the quarter.
  • Avior Wealth Management sold 6 Harmony Biosciences shares in Q2 2024, an estimated $201.
  • Avior Wealth Management first reported a position in Harmony Biosciences in Q1 2024 and held it in 1 quarter.
  • Avior Wealth Management's Harmony Biosciences position peaked at $201 in Q1 2024.
  • 219 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2024.

Based on Avior Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.